A previous body of work in bovine and rodent models shows that cholinergic agonists modulate the secretion of steroid hormones from the adrenal cortex. In this study we used live-cell Ca 2+ imaging to investigate cholinergic activity in the HAC15 human adrenocortical carcinoma cell line. The cholinergic agonists carbachol and acetylcholine triggered heterogeneous Ca 2+ oscillations that were strongly inhibited by antagonists with high affinity for the M 3 muscarinic receptor subtype, while preferential block of M 1 or M 2 receptors was less effective. Acute exposure to carbachol and acetylcholine modestly elevated aldosterone secretion in HAC15 cells, and this effect was also diminished by M 3 inhibition. HAC15 cells expressed relatively high levels of mRNA for M 3 and M 2 receptors, while M 1 and M 5 mRNA were much lower. In conclusion, our data extend previous findings in nonhuman systems to implicate the M 3 receptor as the dominant muscarinic receptor in the human adrenal cortex.
Introduction
Aldosterone is the major mineralocorticoid hormone that regulates body electrolyte and fluid homeostasis (Fuller and Young, 2005) . Synthesized and secreted from the glomerulosa layer of the adrenal cortex, aldosterone targets the distal tubule and collecting duct of the renal nephron, increasing the expression of basolateral Na + -K + ATPase and luminal K + channels. The principal direct consequences are Na + reclamation from and K + excretion into the ultrafiltrate, which in turn powerfully influences total body water and blood pressure. Proper maintenance of the aldosterone system is crucial: severe hypoaldosteronism typical of adrenal crisis can be fatal, while hyperaldosteronism is present in about 10% of primary hypertension cases and an even higher proportion of resistant hypertension cases that do not respond to drug treatment (Calhoun et al., 2008) . While serum K + and angiotensin II are the most important controllers of aldosterone in mammals, numerous other signalers have shown potential to modulate aldosterone production, including adrenocorticotropic hormone (ACTH), dopamine, atrial natriuretic peptide (ANP), endothelin-1, and acetylcholine (Bollag, 2014; Spät and Hunyady, 2004) . The physiologic importance of these potential modulators is largely uncertain. A variety of studies using preparations derived from rodent and bovine adrenal cortex show that cholinergic agonists, such as acetylcholine or carbachol, mobilize intracellular Ca 2+ and increase steroid secretion, presumably via activation of the M 3 muscarinic receptor subtype (Bollag et al., 1992; Jánossy et al., 1998; Kojima et al., 1986) . Beyond this, the precise cellular mechanisms underlying cholinergic regulation of aldosterone production, and whether it is of physiological consequence, remains unclear. The human adrenocortical carcinoma monoclonal cell line HAC15 is a subclone of the polyclonal H295R cell line (Wang and Rainey, 2012) . HAC15 cells have pluripotential properties and as such can be induced to express all the enzymes necessary to manufacture the steroid hormones produced by the three functionally distinct layers of the adrenal cortex. This has made the HAC15 line an important and popular model for studying cellular and molecular mechanisms that govern steroid hormone production. A survey of recent literature shows that HAC15 cells have been used to explore the contrasting effects of thiazolidinedione drugs on cortisol and aldosterone production (Pan et al., 2014) hyperaldosteronism (Hattangady et al., 2016; Oki et al., 2012) , and to establish a role for Ca 2+ /calmodulin-dependent protein kinase kinase in regulating steroidogenesis (Nanba et al., 2015) . Thus, it is clear that a comprehensive understanding of the steroid biology of HAC15 cells is a worthwhile goal. Nonetheless, cholinergic regulation of steroid hormone synthesis and secretion has not been scrutinized in these cells or to our knowledge any other human cell model. In the following study, we investigated the relationship between cholinergic receptor activity, intracellular Ca 2+ homeostasis, and aldosterone production in HAC15 cells.
Materials and methods

Materials
Fluo-4, AM and cell culture reagents were purchased from Life Technologies, all other materials were from Sigma Aldrich. HAC15 cells were kindly provided by Dr. William Rainey. For ELISAs, the primary antibody against aldosterone was kindly provided by Dr. Celso GomezSanchez.
Cell culture
HAC15 cells were cultured in monolayers on collagen-coated surfaces, in growth media containing DMEM/F12, 10% Cosmic calf serum, 1% penicillin/streptomycin, 1% ITS + Premix and 0.1% gentamicin at 37°C, 5% CO 2 . For microscopy experiments, 25 mm or 18 mm glass coverslips were coated with collagen one day prior to plating, and cells were plated in 6-well or 12-well plates at a density of 100,000 or 50,000 per well, respectively. After 2 days, media was replaced with steroidogenic media (same as growth medium but containing 0.1% Cosmic calf serum) and cells were used in experiments 1-2 weeks later.
Fluorescence imaging
All imaging experiments were performed at room temperature on an IX70 Olympus fluorescence microscope equipped with a 40× oil-immersion objective (UAPO/340, ND = 1.35). The chamber was perfused with HEPES buffer containing (in mM): 140 NaCl, 0.5 KH 2 PO 4 , 3.1 KCl, 2 NaHCO 3 , 0.9 MgSO 4 , 5 HEPES, 5.5 glucose, 0.25 sulfinpyrazone, and 0.05 EGTA, pH adjusted to 7.4 with NaOH. Varying concentrations of drugs were diluted in buffer from 1000× stock solutions and perfused onto the cells to monitor dye response. Coverslips were incubated in 5 μM Fluo-4 AM in HEPES buffer (supplemented with 5 mg/mL BSA and 10 μM N,N,N′,N′-Tetrakis (2-pyridylmethyl)ethylenediamine (TPEN) for 30 min at 25°C) and then placed in a 500 μL perfusion chamber and mounted onto the microscope stage. During experiments, cells were perfused with buffer at a rate of 5 mL/min. Excitation light was provided by a xenon lamp-based Lambda LS stand-alone illuminator (Sutter Instruments). Incident light and emission signal was selected by a 480 nm band-pass excitation filter, a 500 nm dichromatic mirror, and a 520 nm long-pass emission filter. Images were captured with an LT Flash4.0 CMOS camera with HCImage acquisition software (Hamamatsu Photonics) in three-second increments. Fluorescence was quantified in a given field from 50 to 100 selected cells and represented as a ratio of fluorescence at any given time (F) divided by the starting, or baseline fluorescence (F 0 ). We did not convert fluorescence values to Ca 2+ concentrations, due to the problematic nature of those calculations (Dineley et al., 2002) .
ELISA
Aldosterone ELISA experiments followed methods previously described (Oki et al., 2013) with the following modifications. Cells were plated on collagen-coated 24-well plates at a density of 200,000/well. After 2 days, media was replaced with steroidogenic media. One-weekold cells were treated with carbachol, acetylcholine or angiotensin II for 60 min or 24 h. In experiments with cholinergic inhibitors, cells were pretreated with antagonists for 10 min before and during the agonist treatment. Supernatant was collected, and aldosterone was measured using SuperSignal™ ELISA Pico Chemiluminescent Substrate, where luminescence was measured at 425 nm. After harvesting supernatant, cells were loaded with Hoechst 33342 (15 μM) for 30 min at 37°C and fluorescence was measured at 460 nm, to ensure consistent cell density between wells.
Real-time PCR
For muscarinic receptor expression experiments, cells were plated at 5,000,000 cells per T25 flask in growth media, replaced 2 days later with steroidogenic media and maintained in culture for 2 weeks. For examination of steroidogenic enzyme expression, HAC15 cells were plated on 6-well plates at a density of 1 × 10 6 cells/well. For both mRNA expression experiments, cells were harvested and RNA was purified using the MasterPure RNA purification kit (Epicenter). Thereafter, the RNA was converted to cDNA using MonsterScript 1st-Strand cDNA Synthesis kit (Epicenter). mRNA expression of muscarinic receptor subtypes (CHRM1, CHRM2, CHRM3, CHRM4, and CHRM5) was detected with manufacturer's instructions using the PerfeCTa SYBR Green SuperMix (VWR) and published primers at a concentration of 300 nM (Table 1 ) (Mansfield et al., 2005) . Muscarinic receptor values were normalized to the expression of the reference gene GAPDH, which was analyzed in parallel wells. In order to determine the relative expression of all the muscarinic receptors, the muscarinic receptor data was normalized to CHRM1. For steroidogenic enzymes, the reaction mixture was comprised of PerfeCTa qPCR ToughMix (Quantabio, Beverly, MA), 500 nM for each primer (see Table 1 ), 250 nM for each probe, and 37.5 ng cDNA/well. PrimeTime qPCR probe-based assays (Integrated DNA Technologies, Coralville, IA) were used to analyze expression of each gene of interest in duplex with the reference gene GAPDH using probe fluorophores of FAM and HEX fluorophores, respectively. Because the primers for CHRM4 did not yield acceptable levels of amplification efficiency, our experiments did not address CHRM4 expression. Tolerance for all other primer sets was 90-110%. Real-time data were obtained during the extension phase and critical threshold cycle values were calculated at the log phase of each gene amplification curve. 
Statistical analyses
All experiments were repeated at least three times using cells from at least three different culture preparations. All data processing and statistical analysis was performed using GraphPad Prism version 7.01 for Windows (GraphPad Software). The frequency of oscillatory activity for each cell was quantified by counting the number of peaks, where a peak was defined by any event where fluorescence, F, exceeded baseline fluorescence, F 0 , by a factor of two. Area under the curve (AUC) measurements were also calculated for all peaks, using Prism built-in functions. Each cell was considered a sample and each microscopy coverslip yielded approximately 50-100 cells. The bars in the summary graphs are represented as the mean number of peaks with 95% CI. We summarized AUC data by one of two methods. We calculated the total area of all peaks for each cell, and we calculated the average area of the individual peaks, for each cell. Both are reported as mean with 95% CI. Aldosterone values were calculated as mean pg/mL ± SEM, represented as fold increase from basal levels, from three replicates each from at least three different culture passages.
For Figs. 4, 6 and 7, Figs. S1 and S2, comparisons were made using one-way ANOVA followed by Dunnett's post-test. Other statistical comparisons used Student's t-test. p value < 0.05 was regarded as significant.
Results
Previous studies in bovine and rodent adrenocortical models have identified cholinergic receptor control over steroid production that is linked to Ca 2+ mobilization. To search for similar activity in the HAC15
human cell line, we began with live-cell imaging experiments using the Ca 2+ -sensitive fluorophore Fluo-4. Fluo-4 is particularly useful in situations where high Ca 2+ sensitivity is helpful due to its bright fluorescence emission and superior accumulation inside cells (Gee et al., 2000) (Fig. 1A) . We found that HAC15 cells exhibited Ca 2+ oscillations when stimulated with carbachol, the stable synthetic analogue of acetylcholine, in a concentration-dependent fashion (Fig. 3A ). Fig. 1 shows a typical sequence of images from the same cells, sampled in three-second intervals during the carbachol treatment (10 μM). Many of the cells experienced oscillations (e.g. those in the circled groups) while others remain quiescent. Fig. 1B -D depict the heterogeneity of the responses. 2 ). This is consistent with PLC-IP 3 second messenger pathways associated with excitatory muscarinic receptors, and moreover is a classic demonstration of the role that store-operated Ca 2+ mechanisms occupy in resupplying the small amounts of Ca 2+ lost from the cell with each cycle of release and recapture (Dupont et al., 2011) . In any case, because extracellular Ca 2+ was not critical for the muscarinic receptormediated oscillations, and because it could contribute to confounding intracellular transients arising from other mechanisms, our imaging experiments omitted Ca 2+ from the superfusate unless otherwise noted.
The extent of oscillation in each cell was quantified as the number of peaks that rose at least two-fold above baseline fluorescence. The frequency histogram in Fig. 2C depicts the large degree of heterogeneity in the population: the average number of Ca 2+ peaks per cell was 5.77
and 5.25 in the presence and absence of extracellular Ca 2+ , respectively. However, between 12 and 14% percent of cells did not respond at all, while 16-20% of cells exhibited more than 10 peaks (and as many as 25) during the five-minute period of stimulus. Cholinergic oscillations were entirely attributable to muscarinic subtypes, because the activity was also triggered by acetylcholine (ACh) and bethanechol, but not by nicotine ( Fig. 3B-D (Quinn et al., 1988; Rössig et al., 1996) . However we were unable to observe oscillations with any concentration of angiotensin II (10pM-100 nM). This discrepancy might be explained by a lack of certain ionic channels in the HAC15 line, compared to primary cells, that are necessary for angiotensin II-induced oscillations (Hu et al., 2012) . If so, this deficiency clearly does not prevent cholinergic oscillations. We next sought to determine which of the five muscarinic subtypes, M 1 -M 5 , regulate the Ca 2+ response, using a panel of muscarinic receptor antagonists with varying subtype preferences: atropine (high affinity but non-selective), tiotropium and darifenacin (M 3 -preferring), pirenzepine (M 1 -preferring) and methoctramine (M 2 -preferring) (Casarosa et al., 2009; Hegde et al., 1997) . For these assays, the inhibitor was included in the superfusate for three minutes before and during the five-minute stimulation with carbachol or ACh. Tiotropium at just 1 μM eliminated virtually all carbachol-induced activity (Fig. 4A) . Fig. 4B and C summarize trials of carbachol or acetylcholine (10 μM) in the presence of muscarinic inhibitors (1 μM), with data expressed as the average number of peaks in the cell population. We also carried out detailed concentration response trials (Fig. 4D) for tiotropium, darifenacin, pirenzepine, and methoctramine, in the presence of carbachol (10 μM). The extent of inhibition was expressed as the percentage of responding cells (i.e. any cell that showed at least one Ca 2+ peak ≥ twice baseline fluorescence was considered a responder).
These curves allowed us to infer IC 50 values for each of the subtypepreferring muscarinic blockers (see Table 2 ). Both of the high-affinity, M 3 -preferring blockers tiotropium and darifenacin potently suppressed oscillations (IC 50 = 0.002 μM and 0.065 μM, respectively). Moderate inhibition was achieved by the M 1 -preferring antagonist pirenzepine (IC 50 = 0.69 μM), whereas the M 2 -preferring blocker methoctramine To compare the Ca 2+ signaling dynamics for different steroidogenic stimuli, we exposed HAC15 cells to angiotensin II (100 nM) for five minutes (Fig. 5A-C) . Similar to the data in Fig. 3E , this elicited robust Ca 2+ changes that took the form of a single, large, and relatively uniform transient that featured little if any oscillatory activity (Fig. 5A) . Atropine (1 μM) had no effect on the frequency of peaks per cell (Fig. 5B) . We also calculated the total area under the curve for all peaks in each cell, for both carbachol and angiotensin II conditions. This showed that the numerous small transients elicited by carbachol (10 μM) constitute a total Ca 2+ load that is roughly equal to the Ca 2+ change caused by angiotensin II (100 nM). However, the individual peaks in the carbachol-treated cells were on average about half the area of the average angiotensin II peak (Fig. 5C ).
Previous studies in models derived from bovine and rodent tissue showed that muscarinic receptor activation can stimulate the production of steroids, albeit to a lesser extent than can be achieved with angiotensin II. We used an ELISA-based aldosterone assay to determine the effects of carbachol and acetylcholine on HAC15 steroid production (Fig. 6 ). Consistent with previous reports, we found that treatment with acetylcholine or carbachol (100 μM) for one hour acutely increased aldosterone secretion, but angiotensin II (100 nM) had no effect (Fig. 6A ). In comparison, angiotensin II for 24 h increased aldosterone production by at least 10-fold, at which time point the effect of the cholinergic agonists had dissipated compared to the one-hour treatment (Fig. 6B) . In either time course, tiotropium (1 μM) blocked aldosterone production, but pirenzepine and methoctramine did not. The antimuscarinics had no effect on angiotensin II-induced aldosterone production. We next asked if the cholinergic agonists caused any changes in the aldosterone synthesis machinery. We used RT-PCR to determine changes in CYP11B1, CYP11B2, and StAR (Table 3) . We found that 24-h treatment with carbachol or acetylcholine (100 μM) caused modest yet statistically significant upregulation of CYP11B1 and CYP11B2, but did not change StAR. In contrast, angiotensin II (100 nM) increased the two CYPs by more than 4-fold, and 15-fold, respectively.
Lastly, we used quantitative RT-PCR to determine the relative mRNA expression for the different muscarinic subtypes (Fig. 7) . Consistent with our pharmacological data, we found that M 3 message was most abundant, at levels roughly 7.5-fold higher than the least abundant M 1 message. M 2 mRNA was also relatively abundant, while M 5 was considerably lower. We were unable to detect mRNA for M 4 . 
Discussion
Our data build upon previous studies in bovine and rodent models to support the conclusion that the M 3 muscarinic receptor is the dominant cholinergic receptor in human adrenal glomerulosa cells. In our experiments, carbachol, acetylcholine, and bethanechol, but not nicotine, stimulated intracellular Ca 2+ oscillations. These were largely attributed to cyclical release and recapture of intracellular ER stores, Muscarinic receptor antagonists possessing high affinity for the M 3 subtype inhibited oscillations nearly completely. Similarly, both acetylcholine and carbachol increased aldosterone production, albeit modestly, and this increase was most effectively diminished by a high affinity, M 3 -preferring inhibitor. Finally, RT-PCR suggests that the mRNA for the M 3 subtype is the most abundant muscarinic receptor transcript in HAC15 cells. Molecular biology has revealed the presence of five distinct muscarinic receptor subtypes in vertebrates, designated M 1 -M 5 (Eglen, 2005) . All are members of the G-protein coupled receptor superfamily and all are found in both CNS and the periphery, but with markedly different patterns of distribution. The activity of parasympathetic effectors is dominated by M 3 and M 2 subtypes. M 3 function is perhaps best understood in smooth muscle, particularly in the airways, bladder, and GI, where activation is linked to PLC-IP 3 pathways that mobilize Ca 2+ and stimulate contraction. M 2 receptors are well delineated in the heart, where they slow pacemaker cell activity via inhibition of adenylate cyclase, reduction of cyclic nucleotides, activation of K + channels, and inhibition of Ca 2+ channels. In tissues possessing multiple muscarinic subtypes, determination of the respective functional contributions is hampered by a lack of truly selective modulators, which is a consequence of the close structural homology shared between all the muscarinic receptors, particularly at their ACh binding sites (Eglen, 2005) . In our experiments, we used the high-affinity antagonists darifenacin and tiotropium to block M 3 receptors. Darifenacin affinity for M 3 is about 70-fold higher than M 2 . Tiotropium is only about three-fold more selective based on affinity alone but is thought to be functionally selective because it remains bound to the M 3 receptor for a much longer duration (Tautermann et al., 2013) . We found that both darifenacin and tiotropium potently and effectively silenced Ca 2+ oscillations triggered by acetylcholine or carbachol, with IC 50 values of 65 and 2.0 nM, respectively. By comparison, the M 1 -preferring antagonist pirenzepine was a moderate inhibitor of Ca 2+ oscillations (IC 50 = 690 nM). The M 2 -preferring methoctramine was weaker yet (IC 50 = 4.27 μM), silencing only about 60% of the cells even at the highest concentration tested (10 μM). The heterogeneous intracellular Ca 2+ response to muscarinic agonists differs from the effects we observed with angiotensin II, which at 100 nM caused a single, large and long-lasting Ca 2+ transient in virtually 100% of cells. By comparison, muscarinic agonists produced a highly diverse set of responses. In Ca 2+ -free conditions, about 12% of cells did not respond at all, while 16% displayed more than 10 peaks, and a small percentage displayed more than 20. To gauge the total peak activity of each cell, AUC for all peaks in a cell were summated. This revealed that the total AUC per cell was not different between the angiotensin II and carbachol conditions. In other words, the many small transients elicited by a modest concentration of muscarinic agonist (10 μM), when added together, constituted a total Ca 2+ load roughly equal to that achieved by a relatively generous concentration of angiotensin II (100 nM). This suggests that perhaps the relative impotence of muscarinic activity in stimulating aldosterone production lies not in an inability to mobilize sufficient amounts of Ca 2+ , but rather the failure to mobilize it simultaneously. From that, it seems reasonable to suggest that the sustained cytosolic Ca 2+ load of angiotensin II would be more conducive to the mitochondrial Ca 2+ accumulation that appears to be critical for stimulating aldosterone synthesis (Szanda et al., 2012; Wiederkehr et al., 2011) . Ca 2+ oscillations are a common phenomenon triggered by numerous GPCRs and documented in a wide variety of cell types (Dupont et al., 2011) . The current view regards the oscillatory mechanism as a finely tuned mode of intracellular signaling that is (i) responsive to low levels of extracellular ligands, and (ii) possesses high signal-to-noise, because true oscillatory activity can be easily distinguished from random fluctuations. While the magnitude of Ca 2+ change with a single oscillation is small, the tight juxtaposition of ER and mitochondria compartments is thought to serve as an intracellular synapse that facilitates Ca 2+ -mediated communication between the two organelles (Csordás et al., 2006) . Given the central role of mitochondria in steroidogenesis, such thinking is particularly intriguing in the adrenal cortex. Nevertheless, the specific function of Ca 2+ oscillations for any cell type remains speculative. A potentially interesting insight gleaned from the present work is that oscillations become more frequent in HAC15 cells that have been growing in steroidogenic media, as opposed to those kept in growth media ( Supplementary Fig. 3 ). This suggests that M 3 receptor control over Ca 2+ becomes more prominent as the cells become poised toward steroidogenesis. Both acetylcholine and carbachol also stimulated aldosterone secretion, but weakly compared to angiotensin II. Treatment with cholinergic agonist for one-hour was sufficient to significantly increase aldosterone secretion. After 24 h, aldosterone still trended higher, but was not significantly different from control, due to the fact that HAC15 cells constantly secrete steroid hormones, regardless of stimulus. In trials using muscarinic receptor antagonists, we found that tiotropium markedly inhibited aldosterone production induced by ACh or carbachol, while pirenzepine and methoctramine did not. Thus, both Ca 2+ oscillation and aldosterone secretion were inhibited most effectively by an M 3 -preferring antagonist. The rapid effects of cholinergic agonists on aldosterone production suggests that muscarinic receptor activation accelerates the release of aldosterone that is already synthesized. However, with longer treatments, cholinergic agonists also appear to moderately upregulate some components of the aldosterone synthesis pathway. These data contrast markedly with the effect of angiotensin II, which had no acute effect on aldosterone secretion, but in the 24-h treatment greatly elevated both aldosterone production and CYP11B1 and CYP11B2 expression. A number of previous reports provided evidence for cholinergic enhancement of cortisol secretion in fasiculata preparations. In some of the earliest work in mammalian systems, Hadjian and colleagues used bovine cortical membranes and fasiculata cells to show that acetylcholine stimulated cortisol production, but to a much weaker degree compared to ACTH (Hadjian et al., 1984 (Hadjian et al., , 1982 1981) . This activity was attributed to muscarinic receptors that stimulated phosphoinositide turnover and Ca 2+ mobilization but did not alter the cyclic nucleotide pool. Subsequent reports using muscarinic agonists in bovine cells suggested that ACh-mediated phosphoinositide turnover and cortisol production was most consistent with M 3 receptors coupled to phospholipase C (Clyne et al., 1994; Jánossy et al., 1999; Walker et al., 1990) . Other work explained the weak steroidogenic effect of carbachol as a consequence of fast internalization of the M 3 receptor (Jánossy et al., 2001 ). Fewer studies have been carried out in glomerulosa models, but their findings are broadly similar: in bovine glomerulosa cells, cholinergic agonists stimulated aldosterone production via mechanisms that relied on phosphoinositide hydrolysis and mobilization of intracellular Ca 2+ (Kojima et al., 1986) . The weak induction of aldosterone production by carbachol, relative to angiotensin II, was ascribed to inadequate mobilization of intracellular Ca 2+ . Later work by Bollag and colleagues suggested that an important distinction between angiotensin II and carbachol was the tendency of carbachol to induce the formation of a comparatively short-lived species of DAG that declines rapidly after agonist removal, possibly because carbachol activation of phospholipase D is transient (Bollag et al., 1992; Jung et al., 1998) . While all the cell-based results, including data in this report, point to the M 3 receptor as the most functionally important muscarinic subtype, at least within the adrenal cortex, a far more complicated picture emerges from studies of physiologically intact systems. In microperfusion experiments with rat capsule-glomerulosa preparations, the M 1 antagonist pirenzepine enhanced aldosterone. This was presumed to result from inhibition of M 1 autoreceptors that inhibit ACh release from parasympathetic postganglionic axons terminating in the cortex (Jánossy et al., 1998) . Interestingly, the authors noted that cholinergic agonists increased aldosterone production in a few samples, but the overall effect in the entire group did not reach statistical significance. These disparate observations raise the possibility that cholinergic activity in the adrenal cortex may differ profoundly between individuals. Another study in mice showed that corticosterone levels are increased five-fold by the mixed modulator BuTAC, which activates M 2 receptors while blocking M 3 (Watt et al., 2013) . This enhancement is lost in mice with targeted disruption of the M 2 receptor (Hemrick-Luecke, 2002) . Unfortunately, that report did not address the location in the HPA axis where this effect occurs. In human males, intravenous atropine inhibited aldosterone secretion stimulated by angiotensin II and metoclopramide, but not by ACTH (Stern et al., 1989) . These studies are interesting in their own right, but when considered together they do not yield a consistent and informative interpretation of cholinergic influence on the aldosterone system. Intriguingly, our RT-PCR data found M 2 mRNA present at levels on par with M 3 . This stands in contrast to one of the aforementioned bovine studies which found mRNA for M 3 , but not for M 2 or M 4 (Jánossy et al., 1999) . (Because the sequences were unknown at the time, it was not possible for the authors to test for bovine M 1 or M 5 .) In our Ca 2+ imaging experiments, the M 2 -preferring blocker methoctramine inhibited oscillations only at high concentrations. We assume this effect arises from methoctramine block at M 3 receptors (methoctramine affinity for M 3 is roughly 800 nM). Consistent with this are numerous previous results in both glomerulosa and fasiculata cells from rat or cow which found that muscarinic activation did not change cyclic nucleotides, as would be expected with classic M 2 second messenger pathways which are known to inhibit adenylate cyclase. However, these data do not rule out a possible role for M 2 receptors in human cortical cells, and it is tempting to speculate that the aforementioned BuTAC influences steroid production via some direct action on cortical M 2 receptors.
Conclusions
Taken together, our results extend to a human glomerulosa model previous findings that identify the M 3 muscarinic receptor as the most important subtype in cholinergic modulation of aldosterone synthesis and secretion. We also suggest that the relatively weak steroidogenic effect associated with cholinergic agonists is partly attributable to the pulsatile nature of Ca 2+ transients triggered by muscarinic receptor activation. Further experiments are needed, particularly in regard to a possible role for the M 2 receptor.
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